Blog - Ducit Blue Solutions

Revolutionising Emergency Care with AI-Powered Nasal Spray for Anaphylaxis (Serious Allergic Reaction)

In a groundbreaking move, the U.S. Food and Drug Administration (FDA) has recently approved the first-ever nasal spray, neffy, for the emergency treatment of anaphylaxis. This approval marks a...

The Ducit Blue Foundation’s 2023/2024 One-Health Antimicrobial Resistance Pan-African Internship/Mentorship Programme – Cohort 3

ByDucit Blue Solutions May 28, 2024 INTERNSHIP

WHAT IS THE DUCIT BLUE FOUNDATION (DBF) ONE-HEALTH ANTIMICROBIAL RESISTANCE PAN-AFRICAN INTERNSHIP/MENTORSHIP PROGRAMME? The Ducit Blue Foundation One-Health Antimicrobial Resistance Pan-African...

Strengthening Healthcare Workforce in Nigeria: the Launch of the Global Health Workforce Programme (GHWP) IN NIGERIA

ByDucit Blue Solutions April 1, 2024 NEWSLETTERS

Nigeria Takes a Step Forward in Building a Stronger Health System The health workforce is the backbone of every healthcare system. However, many countries, including Nigeria, face challenges like...

Leading the way: Ducit Blue Foundation Unveils Cohort 3 of the One Health Pan African AMR Internship/Mentorship Program: Nurturing Youth Champions to Confront Antimicrobial Resistance Directly

ByDucit Blue Solutions December 20, 2023 NEWSLETTERS

Ducit Blue Foundation is excited to share the exciting news of the launch of the 3rd Cohort of our transformative One Health Pan African AMR Internship/Mentorship Program. This aligns with our...

Ruminating on the Amref International University Inaugural Primary Healthcare Congress: Insights from the Ducit Blue Foundation One Health Pan African AMR Interns

ByDucit Blue Solutions December 6, 2023 NEWSLETTERS

Authors: Hafeez Hamza, Nereah Riaga, and Kenneth Egwu Photo: Hafeez Hamza (L) and Nereah Riaga (R) representing Ducit Blue Foundation (DBF) at the Amref International University 1st Primary Healthcare...